• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Long-term follow-up of patients with chronic chagas disease and implantable cardioverter-defibrillator.慢性恰加斯病患者与植入式心脏复律除颤器的长期随访
Pacing Clin Electrophysiol. 2014 Jun;37(6):751-6. doi: 10.1111/pace.12342. Epub 2014 Jan 27.
2
Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.植入式心脏复律除颤器用于恰加斯心脏病二级预防的长期随访。
Am J Cardiol. 2012 Oct 1;110(7):1040-5. doi: 10.1016/j.amjcard.2012.05.040. Epub 2012 Jun 20.
3
Predictors of Appropriate Therapies and Death in Patients with Implantable Cardioverter-Defibrillator and Chronic Chagas Heart Disease.植入式心脏复律除颤器和慢性恰加斯心脏病患者的适当治疗和死亡预测因素。
Arq Bras Cardiol. 2024 Aug 19;121(6):e20230337. doi: 10.36660/abc.20230337. eCollection 2024.
4
Predictors of mortality and heart transplantation in patients with Chagas' cardiomyopathy and ventricular tachycardia treated with implantable cardioverter-defibrillators.植入式心脏复律除颤器治疗恰加斯心肌病伴室性心动过速患者的死亡率和心脏移植预测因素。
Europace. 2019 Jul 1;21(7):1070-1078. doi: 10.1093/europace/euz012.
5
Predictors of all-cause 1-year mortality in implantable cardioverter defibrillator patients with chronic Chagas' cardiomyopathy.植入式心脏复律除颤器治疗的慢性恰加斯心肌病患者全因1年死亡率的预测因素
Pacing Clin Electrophysiol. 2011 Sep;34(9):1063-9. doi: 10.1111/j.1540-8159.2011.03108.x. Epub 2011 Apr 28.
6
Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.接受植入式心脏复律除颤器治疗的慢性恰加斯心脏病患者全因死亡率的预测因素。
J Cardiovasc Electrophysiol. 2007 Dec;18(12):1236-40. doi: 10.1111/j.1540-8167.2007.00954.x. Epub 2007 Sep 26.
7
Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease.植入式心脏复律除颤器在恰加斯病患者中的疗效和安全性。
Europace. 2013 Jul;15(7):957-62. doi: 10.1093/europace/eut011. Epub 2013 Feb 1.
8
Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.无再同步功能的心脏除颤器植入后患者生存率的决定因素。
Kardiol Pol. 2012;70(11):1099-110.
9
Chagas disease is associated with a worse prognosis at 1-year follow-up after implantable cardioverter-defibrillator for secondary prevention in heart failure patients.心力衰竭患者植入式心律转复除颤器二级预防后 1 年随访时,恰加斯病与预后较差相关。
J Cardiovasc Electrophysiol. 2019 Nov;30(11):2448-2452. doi: 10.1111/jce.14164. Epub 2019 Sep 18.
10
Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients.植入式心脏复律除颤器患者中抗心动过速起搏终止的室性心律失常的临床过程和预后相关性。
Europace. 2015 Jul;17(7):1068-75. doi: 10.1093/europace/euv007. Epub 2015 Feb 16.

引用本文的文献

1
Is it Fair to Contraindicate Cardiac Defibrillator Implantation for Patients with Socioeconomic or Psychological Vulnerability?对具有社会经济或心理脆弱性的患者禁忌植入心脏除颤器是否公平?
Arq Bras Cardiol. 2024 Dec 2;121(10):e20240643. doi: 10.36660/abc.20240643. eCollection 2024.
2
Unraveling the Missing Pieces: Exploring the Gaps in Understanding Chagas Cardiomyopathy.解开缺失的环节:探索恰加斯心肌病认识上的差距。
Cureus. 2024 Aug 15;16(8):e66955. doi: 10.7759/cureus.66955. eCollection 2024 Aug.
3
Predictors of Appropriate Therapies and Death in Patients with Implantable Cardioverter-Defibrillator and Chronic Chagas Heart Disease.植入式心脏复律除颤器和慢性恰加斯心脏病患者的适当治疗和死亡预测因素。
Arq Bras Cardiol. 2024 Aug 19;121(6):e20230337. doi: 10.36660/abc.20230337. eCollection 2024.
4
Mortality Risk Stratification in Heart Failure. The Search for the Holy Grail Continues! Autonomic Nervous System Analysis is Back!心力衰竭中的死亡风险分层。对圣杯的探寻仍在继续!自主神经系统分析回归了!
Arq Bras Cardiol. 2023 Feb;120(11):e20230761. doi: 10.36660/abc.20230761.
5
SBC Guideline on the Diagnosis and Treatment of Patients with Cardiomyopathy of Chagas Disease - 2023.巴西心脏病学会2023年恰加斯病心肌病患者诊断与治疗指南
Arq Bras Cardiol. 2023 Jun 26;120(6):e20230269. doi: 10.36660/abc.20230269.
6
Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta-analysis.慢性恰加斯心肌病的死亡风险:系统评价和荟萃分析。
ESC Heart Fail. 2021 Dec;8(6):5466-5481. doi: 10.1002/ehf2.13648. Epub 2021 Oct 30.
7
Chronic Chagas Cardiomyopathy Patients and Resynchronization Therapy: a Survival Analysis.慢性恰加斯心肌病患者与心脏再同步治疗:一项生存分析。
Braz J Cardiovasc Surg. 2018 Jan-Feb;33(1):82-88. doi: 10.21470/1678-9741-2017-0134.
8
Chagas Heart Failure in Patients from Latin America.拉丁美洲患者的恰加斯病性心力衰竭
Card Fail Rev. 2016 Nov;2(2):90-94. doi: 10.15420/cfr.2016:14:2.
9
Echocardiographic Predictors of Worse Outcome After Cardiac Resynchronization Therapy.心脏再同步治疗后预后较差的超声心动图预测指标
Arq Bras Cardiol. 2015 Dec;105(6):552-9. doi: 10.5935/abc.20150108. Epub 2015 Sep 4.
10
The Epidemiology, Clinical Manifestations, and Management of Chagas Heart Disease.恰加斯心脏病的流行病学、临床表现及治疗
Clin Cardiol. 2015 Sep;38(9):565-9. doi: 10.1002/clc.22421. Epub 2015 May 21.

本文引用的文献

1
Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.植入式心脏复律除颤器用于恰加斯心脏病二级预防的长期随访。
Am J Cardiol. 2012 Oct 1;110(7):1040-5. doi: 10.1016/j.amjcard.2012.05.040. Epub 2012 Jun 20.
2
Predictors of all-cause 1-year mortality in implantable cardioverter defibrillator patients with chronic Chagas' cardiomyopathy.植入式心脏复律除颤器治疗的慢性恰加斯心肌病患者全因1年死亡率的预测因素
Pacing Clin Electrophysiol. 2011 Sep;34(9):1063-9. doi: 10.1111/j.1540-8159.2011.03108.x. Epub 2011 Apr 28.
3
Implantable cardioverter-defibrillator therapy for primary prevention of sudden cardiac death in patients with severe Chagas cardiomyopathy.植入式心脏复律除颤器治疗用于严重恰加斯心肌病患者心脏性猝死的一级预防
Int J Cardiol. 2011 Jul 1;150(1):94-5. doi: 10.1016/j.ijcard.2011.03.036. Epub 2011 Apr 16.
4
Predictors of mortality in patients with Chagas' cardiomyopathy and ventricular tachycardia not treated with implantable cardioverter-defibrillators.未接受植入式心脏复律除颤器治疗的恰加斯心肌病合并室性心动过速患者的死亡率预测因素。
Pacing Clin Electrophysiol. 2011 Jan;34(1):54-62. doi: 10.1111/j.1540-8159.2010.02896.x. Epub 2010 Oct 14.
5
Effects of B-Blockers on outcome of patients with Chagas' cardiomyopathy with chronic heart failure.β受体阻滞剂对伴有慢性心力衰竭的恰加斯心肌病患者结局的影响。
Int J Cardiol. 2011 Sep 1;151(2):205-8. doi: 10.1016/j.ijcard.2010.05.033. Epub 2010 Jul 1.
6
Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America.植入式心律转复除颤器与恰加斯病:拉丁美洲植入式心律转复除颤器注册研究结果
Europace. 2009 Feb;11(2):164-8. doi: 10.1093/europace/eun325. Epub 2008 Dec 3.
7
Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.接受植入式心脏复律除颤器治疗的慢性恰加斯心脏病患者全因死亡率的预测因素。
J Cardiovasc Electrophysiol. 2007 Dec;18(12):1236-40. doi: 10.1111/j.1540-8167.2007.00954.x. Epub 2007 Sep 26.
8
Development and validation of a risk score for predicting death in Chagas' heart disease.用于预测恰加斯心脏病死亡风险评分的开发与验证
N Engl J Med. 2006 Aug 24;355(8):799-808. doi: 10.1056/NEJMoa053241.
9
Sudden cardiac death in patients with chagas heart disease and preserved left ventricular function.
J Cardiovasc Electrophysiol. 2006 Jan;17(1):113-6. doi: 10.1111/j.1540-8167.2005.00315.x.
10
Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.β受体阻滞剂、胺碘酮联合β受体阻滞剂或索他洛尔预防植入式心律转复除颤器电击的比较:OPTIC研究:一项随机试验。
JAMA. 2006 Jan 11;295(2):165-71. doi: 10.1001/jama.295.2.165.

慢性恰加斯病患者与植入式心脏复律除颤器的长期随访

Long-term follow-up of patients with chronic chagas disease and implantable cardioverter-defibrillator.

作者信息

Pereira Francisca Tatiana Moreira, Rocha Eduardo Arrais, Monteiro Marcelo de Paula Martins, Neto Almino Cavalcante Rocha, Daher Elisabeth de Francesco, Sobrinho Carlos Roberto Martins Rodrigues, Pires Neto Roberto da Justa

机构信息

Department of Community Health, Faculty of Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil; Division of Pacemaker and Electrophisiology, Hospital Universitário Walter Cantídio, Federal University of Ceará, Fortaleza, Ceará, Brazil.

出版信息

Pacing Clin Electrophysiol. 2014 Jun;37(6):751-6. doi: 10.1111/pace.12342. Epub 2014 Jan 27.

DOI:10.1111/pace.12342
PMID:24467488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4285790/
Abstract

BACKGROUND/OBJECTIVES: Chronic Chagas heart disease (ChHD) is associated with ventricular tachyarrhythmias and an increased risk of sudden cardiac death. Little is known about the effectiveness of implantable cardioverter-defibrillator (ICD) therapy in this population. The objective of this study was to evaluate the efficacy of ICD in patients with ChHD and to identify predictors of mortality and appropriate ICD shocks.

METHODS

The cohort study included 65 patients with ChHD and ICD for primary and secondary prevention of sudden death. The Cox model was applied to evaluate the predictors of mortality, and survival was assessed by Kaplan-Meier analysis.

RESULTS

The median age was 56 ± 11.9 years. The median follow-up was 40 ± 26.8 months. Among the patients 23 (36.5%) had appropriate shocks. A total of 13 (20%) patients died (6.1% of annual mortality rate), and there was no sudden death. In univariate Cox model, functional class IV (hazard ratio [HR] = 1.99; 95% confidence interval [CI], 1.05-3.76; P = 0.034), primary prevention (HR = 0.29; 95% CI, 0.09-0.99; P = 0.048), lower education (HR = 2.51; 95% CI, 1.05-5.99; P = 0.038), and ejection fraction <30% (HR = 2.80; 95% CI, 1.09-7.18; P = 0.032) were predictors of worse prognosis (death). In the multivariate Cox model, an ejection fraction <30% and the low education remained predictors of poor prognosis. Predictors of appropriate shocks were not found.

CONCLUSIONS

The ICD was effective for the prevention of sudden cardiac death in patients with chronic ChHD. An ejection fraction <30% and low education were predictors of poor prognosis.

摘要

背景/目的:慢性恰加斯心脏病(ChHD)与室性快速性心律失常及心脏性猝死风险增加相关。关于植入式心脏复律除颤器(ICD)治疗该人群的有效性知之甚少。本研究的目的是评估ICD对ChHD患者的疗效,并确定死亡率和ICD恰当电击的预测因素。

方法

该队列研究纳入了65例因心脏性猝死的一级和二级预防而植入ICD的ChHD患者。应用Cox模型评估死亡率的预测因素,并通过Kaplan-Meier分析评估生存率。

结果

中位年龄为56±11.9岁。中位随访时间为40±26.8个月。在患者中,23例(36.5%)接受了恰当电击。共有13例(20%)患者死亡(年死亡率为6.1%),且无心脏性猝死。在单变量Cox模型中,心功能IV级(风险比[HR]=1.99;95%置信区间[CI],1.05 - 3.76;P = 0.034)、一级预防(HR = 0.29;95% CI,0.09 - 0.99;P = 0.048)、低教育水平(HR = 2.51;95% CI,1.05 - 5.99;P = 0.038)和射血分数<30%(HR = 2.80;95% CI,1.09 - 7.18;P = 0.032)是预后较差(死亡)的预测因素。在多变量Cox模型中,射血分数<30%和低教育水平仍是预后不良的预测因素。未发现恰当电击的预测因素。

结论

ICD对预防慢性ChHD患者的心脏性猝死有效。射血分数<30%和低教育水平是预后不良的预测因素。